Fortrea
Margarete Rudloff is a seasoned professional in clinical data management and monitoring, currently serving as the Director of Central Monitoring at Fortrea since June 2023. Prior experience includes key leadership roles at Labcorp Drug Development from January 2013 to June 2023, overseeing Clinical Development in Germany, Austria, and Switzerland, along with positions in monitoring operations and risk-based monitoring. Margarete's career also encompasses significant contributions at Covance, INC Research, Kendle, and gmi, demonstrating extensive expertise in project management, client relationships, and data operations across Europe and Asia Pacific. Margarete holds a degree as a Medical Documentalist from Justus-Liebig-University in Gießen, Germany, focusing on data operations, medicine, mathematics, statistics, and public health law.
This person is not in the org chart
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.